State Street
SXLV.L
IE00BWBXM617
State Street® SPDR® S&P® U.S. Health Care Select Sector UCITS ETF (Acc)
Loading chart...

Analytics & Allocation

Detailed breakdown by growth drivers, valuation & quality, and asset allocation

Growth Drivers (Estimates)

Largest contributors to earnings and revenue growth

Balance Sheet & Financial Health

Aggregated leverage and valuation structure

Weighted P/E
30.7
Weighted Fwd P/E
17.45
Avg P/FCF
25.33
Avg FCF Yield
3.92%
Avg EV / EBITDA
18.05
Avg EV / Revenue
6.7
Avg Price-to-Book (P/B)
23.53
Avg Price-to-Sales (P/S)
6.39
Avg Dividend Yield
0.00%
P/E Compression (Trailing vs Fwd)
-43.17%
Avg Debt-to-Equity (D/E)
206.90%
<50% (9.55%) 50-150% (50.22%) >150% (26.59%) Unreported (13.63%)

Profitability Analysis

59 Holdings Count
Profitable 99.08%
Profitable 99.08%
58 Holdings Count (98.31%)
Unprofitable 0.92%
1 Holdings Count (1.69%)

ETF Concentration (Cumulative Weight)

Cumulative weight of positions (Lorenz curve)

High Concentration (Top-Heavy)
Top 5
45.0%
Top 10
61.0%
Top 25
85.0%
50% Threshold
Top 7
The top 10 holdings account for 61% of the total ETF. Performance is heavily driven by a few heavyweights. The steeper the curve initially rises, the more the largest positions dominate the fund volume.

Geographic Distribution

3 Countries
Loading TopoJSON Map...
0% (No exposure)
Tiers:
Low (0.1%+)
Med (24.4%+)
High (63.4%+)
Top (87.8%+)

Country Breakdown

Max: 97.57%
US US US
97.57%
IE IE IE
1.96%
CH CH CH
0.47%

Sector Distribution

1 Sector
Healthcare
100.00%

Industry Distribution

10 Industries
Drug Manufacturers - General
51.11%
Healthcare Plans
11.47%
Diagnostics & Research
10.91%
Medical Devices
10.23%
Biotechnology
4.92%
Medical Instruments & Supplies
4.78%
Medical Distribution
3.74%
Other
2.84%

Market Cap Distribution

59 Holdings Count
Mega Cap (> 200B)
(7) 52.42%
Large Cap (10B - 200B)
(47) 46.78%
Mid Cap (2B - 10B)
(5) 0.79%
ende